Viewing Study NCT06130995


Ignite Creation Date: 2025-12-24 @ 2:14 PM
Ignite Modification Date: 2026-02-28 @ 10:38 PM
Study NCT ID: NCT06130995
Status: RECRUITING
Last Update Posted: 2025-02-11
First Post: 2023-11-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Relugolix + Enzalutamide Study in High-Risk Prostate Cancer
Sponsor: University of Oklahoma
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module